Canada markets open in 4 hours 55 minutes

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.6900-0.0400 (-1.07%)
At close: 04:00PM EDT
3.6100 -0.08 (-2.17%)
After hours: 04:08PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
17,083
47,112
38,704
57,064
-
Other Short Term Investments
13,686
4,225
9,868
9,309
-
Total Cash
30,769
51,337
48,572
66,373
-
Net Receivables
9,551
12,973
9,803
4,645
-
Inventory
15,877
6,138
1,907
1,356
-
Other Current Assets
2,560
2,975
1,688
1,651
-
Total Current Assets
59,344
73,423
61,970
74,025
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
16,284
15,528
24,063
12,496
-
Accumulated Depreciation
-4,651
-2,299
-2,244
-1,738
-
Net property, plant and equipment
11,633
13,229
21,819
10,758
-
Equity and other investments
1,681
7,463
40,128
29,442
-
Intangible Assets
1,839
1,063
12,203
13,210
-
Other long-term assets
766
1,056
2,178
299
-
Total non-current assets
15,924
22,811
76,328
53,709
-
Total Assets
75,268
96,234
138,298
127,734
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
-
1,292
-
Accounts Payable
4,438
3,289
2,223
3,260
-
Taxes payable
0
1,900
0
-
-
Accrued liabilities
538
648
60
49
-
Deferred revenues
2,543
2,617
-
-
-
Other Current Liabilities
-
648
519
-
-
Total Current Liabilities
16,726
17,005
13,186
7,976
-
Non-current liabilities
Long Term Debt
18,895
-
-
-
-
Deferred revenues
-
0
2,828
2,351
0
Other long-term liabilities
11,821
11,821
13,220
12,869
-
Total non-current liabilities
34,377
12,297
17,153
16,185
-
Total Liabilities
51,103
29,302
30,339
24,161
-
Stockholders' Equity
Common Stock
1
1
1
1,240
-
Retained Earnings
-660,817
-637,160
-605,643
-570,501
-
Accumulated other comprehensive income
-1,200
-703
1,954
589
-
Total stockholders' equity
24,165
44,574
84,502
81,540
-
Total liabilities and stockholders' equity
75,268
96,234
138,298
127,734
-